# The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture

> **NCT00481585** · — · TERMINATED · sponsor: **Hackensack Meridian Health** · enrollment: 13 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00481585
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2009-07
- **Final completion:** —
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** study team failed to complete timely reviews, study suspended
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00481585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00481585, "The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00481585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*